SGA
TARO

Strategic Global Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Strategic Global Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-73,431
Closed -$6.27M – 170
2019
Q2 		$6.27M Buy
73,431
+1,123
+2% +$111K 1.34% 14
2019
Q1 		$7.82M Buy
72,308
+308
+0.4% +$30.7K 1.64% 11
2018
Q4 		$6.09M Sell
72,000
-1,898
-3% -$183K 2.18% 10
2018
Q3 		$7.26M Sell
73,898
-180
-0.2% -$19.5K 2.2% 10
2018
Q2 		$7.31M Hold
74,078
– – 1.86% 14
2018
Q1 		$7.31M Hold
74,078
– – 2.5% 7
2017
Q4 		$7.76M Sell
74,078
-741
-1% -$81.4K 2.52% 7
2017
Q3 		$8.43M Sell
74,819
-780
-1% -$84.9K 3.23% 5
2017
Q2 		$8.47M Sell
75,599
-5,142
-6% -$581K 3.12% 5
2017
Q1 		$9.42M Sell
80,741
-691
-0.8% -$76.5K 3.4% 5
2016
Q4 		$8.57M Buy
81,432
+1,201
+1% +$126K 3.18% 5
2016
Q3 		$11.3M Hold
80,231
– – 4.23% 4
2016
Q2 		$11.7M Buy
80,231
+12,708
+19% +$1.8M 4.42% 4
2016
Q1 		$9.67M Buy
67,523
+19,369
+40% +$2.75M 4.11% 4
2015
Q4 		$7.44M Buy
48,154
+22,383
+87% +$3.27M 3.17% 4
2015
Q3 		$3.68M Sell
25,771
-21,177
-45% -$2.96M 1.76% 11
2015
Q2 		$6.75M Buy
46,948
+4,048
+9% +$577K 3.94% 3
2015
Q1 		$6.05M Buy
42,900
+454
+1% +$69.9K 4.47% 2
2014
Q4 		$6.29M Buy
+42,446
New +$6.24M 5.6% 2

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Strategic Global Advisors's TARO Position: Q3 2019 in Review

Strategic Global Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2019, closing a stake of 73,431 shares — an estimated $6.27M sold.

Strategic Global Advisors first reported a position in TARO in Q4 2014 and held it in 19 quarters. The position peaked at $11.7M in Q2 2016. 101 funds tracked by Wall St. Rank hold TARO as of Q3 2019.

  • Strategic Global Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2019 after selling out during the quarter.
  • Strategic Global Advisors sold 73,431 Taro Pharmaceutical Industries Ltd. shares in Q3 2019, an estimated $6.27M.
  • Strategic Global Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 19 quarters.
  • Strategic Global Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $11.7M in Q2 2016.
  • 101 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2019.

Based on Strategic Global Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.